FB pixel
Request Support
Request Info
Resources|Area of Interest|Radiation Research|Using SARRP to measure orthotopic prostate cancers: SPOTLIGHT Journal Club Webinar

Using SARRP to measure orthotopic prostate cancers: SPOTLIGHT Journal Club Webinar

March 4, 2025

In this webinar, Dr. Rebecca Oberley-Deegan, from the University of Nebraska, discusses a new technique developed on the SARRP to generate high quality images for measuring orthotopic prostate cancer in mice. This user-led event highlights the work performed and the tips and tricks that enabled this application on SARRP.

Contact Us

Find out more about how Xstrahl will work tirelessly for you

Contact Us

Explore Related Posts

Xstrahl to Highlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Selective Benign Conditions at ACRO Summit 2025 in Las Vegas

Xstrahl to Highlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Selective Benign Conditions at ACRO Summit 2025 in Las Vegas

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.

read more
Non-homogenous intratumor radiation research

Non-homogenous intratumor radiation research

Xstrahl in Action The efficacy and side effects of radiotherapy (RT) depend on parameters like dose and the volume of irradiated tissue. RT induces modulations of the tumor immune microenvironment (TIME) that are dependent on the dose. Low dose RT (LDRT, i.e., single...

read more